Table 1. Anthropometric data.
| Anthropometric data | |||||
|---|---|---|---|---|---|
| Sedentary-Placebo (n = 9) | Sedentary-ESA (n = 9) | Training-Placebo (n = 10) | Training-ESA (n = 8) | Interaction p-value | |
| Age (years) | 25.2 ± 1.6 | 22.7 ±1.0 | 20.9 ± 0.6 # | 25.3 ± 1.7 | 0.046* |
| Weight (kg) | 79.2 ± 3.3 | 82.1 ± 3.4 | 74.2 ± 2.7 | 78.8 ± 5.9 | 0.519 |
| Height (m) | 1.82 ± 0.02 | 1.87 ± 0.02 | 1.83 ± 0.02 | 1.81 ± 0.04 | 0.359 |
| VO2max (L/min) | 3.37 ± 0.20 | 3.56 ± 0.13 | 3.28 ± 0.18 | 3.05 ± 0.2 | 0.273 |
| Erythrocytes (EVF) | 42.8 ± 0.7 | 42.1 ±0.5 | 41.8 ± 0.6 | 42.1 ± 0.9 | 0.756 |
Data are expressed as mean ± SE. Significant interaction
* p<0.05, different from sedentary-placebo and training-ESA # p<0.05. EVF; erythrocyte volume fraction.
Serum samples were drawn before treatment/training were started (t = 0), after the boosting period (t = 3 weeks), after the treatment period (t = 10 weeks), and after a 3-week washout period (t = 13 weeks). Serum samples were centrifuged after collection (10 min, 4°C, 3,800 rpm) and stored at -20°C.